Exact Mass: 218.1168

Exact Mass Matches: 218.1168

Found 161 metabolites which its exact mass value is equals to given mass value 218.1168, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

L-Lysopine

6-amino-2-[(1-carboxyethyl)amino]hexanoic acid

C9H18N2O4 (218.1267)


L-Lysopine is isolated from crown gall tumours of various plants including tomato, jerusalem artichoke and salsify. Isolated from crown gall tumours of various plants including tomato, jerusalem artichoke and salsify. N2-[(1R)-1-Carboxyethyl]-L-lysine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=34522-31-1 (retrieved 2024-08-20) (CAS RN: 34522-31-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

THIOFANOX

2-Butanone, 3,3-dimethyl-1-(methylthio)-, O-[(methylamino)carbonyl]oxime

C9H18N2O2S (218.1089)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Di-tert-butyl dicarbonate

Di-tert-butyl dicarbonate

C10H18O5 (218.1154)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3156

   

Meprobamate

2-[(carbamoyloxy)methyl]-2-methylpentyl carbamate

C9H18N2O4 (218.1267)


A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of anxiety disorders, and also for the short-term management of insomnia but has largely been superseded by the benzodiazepines. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Meprobamate is a controlled substance in the U.S. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BC - Carbamates D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

3-Hydroxysebacic acid

(3R)-3-hydroxydecanedioic acid

C10H18O5 (218.1154)


3-Hydroxydecanedioic is a dicarboxylic acid that belongs to the class of compounds known hydroxy fatty acids. Hydroxy fatty acids are fatty acids that have hydroxyl functional groups attached to the principal chain. 3-Hydroxydecanedioic acid is found in most vertebrates. Urine from patients with ketoacidosis typically contains a number of aliphatic 3-hydroxy dicarboxylic acids, with the major compound being 3-hydroxydecanedioic acid (PMID: 7353273). The excretion of 3-hydroxydecanedioic acid is correlated with the excretion of hexanedioic acid, another metabolite frequently found in ketoacidosis (PMID: 5031780). It is thought that the 3-hydroxy dicarboxylic acids such as 3-hydroxydecanedioic acid are formed from fatty acids by a combination of omega-oxidation and incomplete beta-oxidation (PMID: 7353273). Marked elevation of urinary 3-hydroxydecanedioic acid has also been reported in a malnourished infant with glycogen storage disease (PMID: 8295400). Subsequent studies have shown that increased amounts of dicarboxylic acids, such as 3-hydroxydecanedioic acid, are typically excreted in human urine under conditions of medium-chain triglyceride (MCT) feeding, abnormal fatty acid oxidation (FAO) and fasting (PMID: 8596483). 3-Hydroxysebacic acid is a normal urinary 3-hydroxydicarboxylic acid metabolite and can be elevated in patients with peroxisomal disorders such as Zellweger syndrome. Marked elevation of urinary 3- Hydroxysebacic acid has also been described in a malnourished infant with glycogen storage disease, mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency (OMIM 300438, a defect in the beta-oxidation of fatty acids characterized by massive excretion of 3-hydroxydicarboxylic acids in the urine and accumulation of 3-hydroxy fatty acids in serum). (PMID 12860034, 14708889, 8295400) [HMDB]

   

Isoleucyl-Serine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-hydroxypropanoate

C9H18N2O4 (218.1267)


Isoleucyl-Serine is a dipeptide composed of isoleucine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Serylleucine

(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanoic acid

C9H18N2O4 (218.1267)


Serylleucine is a dipeptide composed of serine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Valylthreonine

(2S)-2-{[(2S)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxybutanoate

C9H18N2O4 (218.1267)


Valylthreonine is a dipeptide composed of valine and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

2-Hydroxydecanedioic acid

alpha-Hydroxysebasic acid

C10H18O5 (218.1154)


2-Hydroxydecanedioic acid appears in the urine of children affected with peroxisomal disorders such as urines of children with neonatal adrenoleukodystrophy and Zellweger syndrome and is a useful marker for these diseases. (PMID 2943344) [HMDB] 2-Hydroxydecanedioic acid appears in the urine of children affected with peroxisomal disorders such as urines of children with neonatal adrenoleukodystrophy and Zellweger syndrome and is a useful marker for these diseases. (PMID 2943344).

   

Leucyl-Serine

2-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-3-hydroxypropanoic acid

C9H18N2O4 (218.1267)


Leucyl-Serine is a dipeptide composed of leucine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Serylisoleucine

(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanoic acid

C9H18N2O4 (218.1267)


Serylisoleucine is a dipeptide composed of serine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Threonylvaline

(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanoic acid

C9H18N2O4 (218.1267)


Threonylvaline is a dipeptide composed of threonine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

5-Hydroxysebacate

5-hydroxydecanedioic acid

C10H18O5 (218.1154)


5-hydroxysebacate is a metabolite found in the urine of patients with peroxismal diseases.

   

Pantothenamide

2,4-Dihydroxy-N-[2-(C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidate

C9H18N2O4 (218.1267)


Pantothenamide is a dietary supplement as a source of pantothenic aci Dietary supplement as a source of pantothenic acid

   

(-)-Menthyl chloroformate

5-methyl-2-(propan-2-yl)cyclohexyl chloroformate

C11H19ClO2 (218.1074)


   

(2R)-2-Amino-2-[[(1S)-1-carboxyethyl]amino]-4-methylpentanoic acid

(2R)-2-Amino-2-[[(1S)-1-carboxyethyl]amino]-4-methylpentanoic acid

C9H18N2O4 (218.1267)


   

N(6)-(1-Carboxyethyl)-L-lysine

2-amino-6-[(1-carboxyethyl)amino]hexanoic acid

C9H18N2O4 (218.1267)


   

Carboxyethyllysine

6-amino-2-[(2-carboxyethyl)amino]hexanoic acid

C9H18N2O4 (218.1267)


   

epsilon-(Carboxyethyl)lysine

epsilon-(Carboxyethyl)lysine

C9H18N2O4 (218.1267)


   

1,3-Propanediol, 2,2-diethyl-, dicarbamate

2-[(carbamoyloxy)methyl]-2-ethylbutyl carbamate

C9H18N2O4 (218.1267)


   

N(epsilon)-(carboxyethyl)lysine

2-amino-6-[(2-carboxyethyl)amino]hexanoic acid

C9H18N2O4 (218.1267)


   

Ser-Leu

2-[(2-Amino-1,3-dihydroxypropylidene)amino]-4-methylpentanoate

C9H18N2O4 (218.1267)


   

Threoninyl-Valine

2-[(2-amino-1,3-dihydroxybutylidene)amino]-3-methylbutanoic acid

C9H18N2O4 (218.1267)


   

3-[(carboxymethoxy)methyl]heptanoic acid

3-[(carboxymethoxy)methyl]heptanoic acid

C10H18O5 (218.1154)


   

(2Z,6S)-3-Chloromethyl-6-methoxyl-7-methylocta-2,7(10)-dien-1-ol|6-Me ether-3-Chloromethyl-7-methyl-2, 7-octadiene-1, 6-diol

(2Z,6S)-3-Chloromethyl-6-methoxyl-7-methylocta-2,7(10)-dien-1-ol|6-Me ether-3-Chloromethyl-7-methyl-2, 7-octadiene-1, 6-diol

C11H19ClO2 (218.1074)


   

(4E)-6,7,9-trihydroxydec-4-enoic acid

(4E)-6,7,9-trihydroxydec-4-enoic acid

C10H18O5 (218.1154)


   

(2Z,6S)-3-Chloromethyl-1-methoxyl-7-methylocta-2,7(10)-dien-6-ol

(2Z,6S)-3-Chloromethyl-1-methoxyl-7-methylocta-2,7(10)-dien-6-ol

C11H19ClO2 (218.1074)


   

Methyl 2,3-O-isopropylidene-a-L-rhamnopyranoside

Methyl 2,3-O-isopropylidene-a-L-rhamnopyranoside

C10H18O5 (218.1154)


   

meprobamate

meprobamate

C9H18N2O4 (218.1267)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BC - Carbamates D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

3-Hydroxysebacic acid

3-Hydroxysebacic acid

C10H18O5 (218.1154)


An alpha,omega-dicarboxylic acid that is decanedioic (sebacic) acid carrying a hydroxy substituent at position 3.

   

1COOH-2But-A7-OCH2COOH

1COOH-2But-A7-OCH2COOH

C10H18O5 (218.1154)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Could be alkyl homologue of given structure; Digitised from figure: approximate intensities

   

Hydroxysebacic acid

Hydroxysebacic acid

C10H18O5 (218.1154)


Annotation level-3

   

isoleucylserine

isoleucylserine

C9H18N2O4 (218.1267)


Annotation level-2

   

serylleucine

serylleucine

C9H18N2O4 (218.1267)


Annotation level-2

   
   
   
   
   
   
   

3-Hydroxysebacate

3-hydroxy-decanedioic acid

C10H18O5 (218.1154)


   

2-Hydroxydecanedioic acid

2-Hydroxydecanedioic acid

C10H18O5 (218.1154)


   

2-hydroxy-decanedioic acid

2-hydroxy-decanedioic acid

C10H18O5 (218.1154)


   

Ile-ser

2-(2-amino-3-hydroxypropanamido)-3-methylpentanoic acid

C9H18N2O4 (218.1267)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials A dipeptide formed from L-isoleucine and L-serine residues. Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Leu-ser

2-(2-amino-3-hydroxypropanamido)-4-methylpentanoic acid

C9H18N2O4 (218.1267)


A dipeptide formed from L-leucine and L-serine residues.

   

Ser-ile

2-(2-amino-3-methylpentanamido)-3-hydroxypropanoic acid

C9H18N2O4 (218.1267)


   

Ser-leu

2-(2-amino-4-methylpentanamido)-3-hydroxypropanoic acid

C9H18N2O4 (218.1267)


A dipeptide formed from L-serine and L-leucine residues.

   

THR-Val

2-(2-amino-3-methylbutanamido)-3-hydroxybutanoic acid

C9H18N2O4 (218.1267)


   

Val-Thr

2-(2-amino-3-hydroxybutanamido)-3-methylbutanoic acid

C9H18N2O4 (218.1267)


   

L-Lysopine

6-amino-2-[(1-carboxyethyl)amino]hexanoic acid

C9H18N2O4 (218.1267)


   

Pantothenamide

N-(2-carbamoylethyl)-2,4-dihydroxy-3,3-dimethylbutanamide

C9H18N2O4 (218.1267)


   

FA 10:1;O3

3-hydroxy-decanedioic acid

C10H18O5 (218.1154)


   

HSC;N-hydroxy-N-succinylcadaverine

4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoic acid

C9H18N2O4 (218.1267)


   

2-METHYL-1-PHENYL-NAPHTHALENE

2-METHYL-1-PHENYL-NAPHTHALENE

C17H14 (218.1095)


   

2-(1,1,2,2,2-pentadeuterioethylamino)-1-phenylpropan-1-one,hydrochloride

2-(1,1,2,2,2-pentadeuterioethylamino)-1-phenylpropan-1-one,hydrochloride

C11H11ClD5NO (218.1234)


   

trimethyl(1-trimethylsilyloxyprop-1-enoxy)silane

trimethyl(1-trimethylsilyloxyprop-1-enoxy)silane

C9H22O2Si2 (218.1158)


   

Ethanol, 2,2-oxybis-,1,1-dipropanoate

Ethanol, 2,2-oxybis-,1,1-dipropanoate

C10H18O5 (218.1154)


   

1-piperidin-4-yl-3H-imidazo[4,5-b]pyridin-2-one

1-piperidin-4-yl-3H-imidazo[4,5-b]pyridin-2-one

C11H14N4O (218.1168)


   

2,2,6,6-tetrakis(hydroxymethyl)cyclohexan-1-one

2,2,6,6-tetrakis(hydroxymethyl)cyclohexan-1-one

C10H18O5 (218.1154)


   

4-piperidin-1-yl-2,1,3-benzoxadiazol-7-amine

4-piperidin-1-yl-2,1,3-benzoxadiazol-7-amine

C11H14N4O (218.1168)


   

acetic acid,N-[2-(hydroxyamino)-2-methylcyclohexylidene]hydroxylamine

acetic acid,N-[2-(hydroxyamino)-2-methylcyclohexylidene]hydroxylamine

C9H18N2O4 (218.1267)


   

1-CYCLOPENTYL-6-FLUORO-3-METHYL-1H-INDAZOLE

1-CYCLOPENTYL-6-FLUORO-3-METHYL-1H-INDAZOLE

C13H15FN2 (218.1219)


   

4-(3-MORPHOLINOPROPYL)-3-THIOSEMICARBAZIDE

4-(3-MORPHOLINOPROPYL)-3-THIOSEMICARBAZIDE

C8H18N4OS (218.1201)


   

1-CYCLOBUTYL-3-ETHYL-6-FLUORO-1H-INDAZOLE

1-CYCLOBUTYL-3-ETHYL-6-FLUORO-1H-INDAZOLE

C13H15FN2 (218.1219)


   
   

diethyl 3-hydroxy-3-methylglutarate

diethyl 3-hydroxy-3-methylglutarate

C10H18O5 (218.1154)


   

(2R,8S)-2,8-DIAMINONONANEDIOIC ACID

(2R,8S)-2,8-DIAMINONONANEDIOIC ACID

C9H18N2O4 (218.1267)


   

2-PIPERIDINYL(1-PYRROLIDINYL)METHANONE HYDROCHLORIDE

2-PIPERIDINYL(1-PYRROLIDINYL)METHANONE HYDROCHLORIDE

C10H19ClN2O (218.1186)


   

7-Fluoro-3-(piperidin-4-yl)-1H-indole

7-Fluoro-3-(piperidin-4-yl)-1H-indole

C13H15FN2 (218.1219)


   

4-Fluoro-3-(piperidin-4-yl)-1H-indole

4-Fluoro-3-(piperidin-4-yl)-1H-indole

C13H15FN2 (218.1219)


   

3-PIPERIDIN-4-YL-1,3-DIHYDRO-IMIDAZO[4,5-B]PYRIDIN-2-ONE

3-PIPERIDIN-4-YL-1,3-DIHYDRO-IMIDAZO[4,5-B]PYRIDIN-2-ONE

C11H14N4O (218.1168)


   

methyl 2,3-o-isopropylidene-alpha-l-rhamnopyranose

Methyl 2,3-o-isopropylidene-alpha-l-rhamnopyranoside

C10H18O5 (218.1154)


   

4-tert-butylcyclohexyl chloroformate

4-tert-butylcyclohexyl chloroformate

C11H19ClO2 (218.1074)


   

4-(4-fluorophenyl)-1-methylpiperidine-4-carbonitrile

4-(4-fluorophenyl)-1-methylpiperidine-4-carbonitrile

C13H15FN2 (218.1219)


   

Naphthalene,2-(phenylmethyl)-

Naphthalene,2-(phenylmethyl)-

C17H14 (218.1095)


   

Ethanone, 1-(2,8-diazaspiro[4.5]dec-8-yl)-, hydrochloride (1:1)

Ethanone, 1-(2,8-diazaspiro[4.5]dec-8-yl)-, hydrochloride (1:1)

C10H19ClN2O (218.1186)


   

5-Fluoro-3-(piperidin-4-yl)-1H-indole

5-Fluoro-3-(piperidin-4-yl)-1H-indole

C13H15FN2 (218.1219)


   

6-Fluoro-3-(piperidin-4-yl)-1H-indole

6-Fluoro-3-(piperidin-4-yl)-1H-indole

C13H15FN2 (218.1219)


   
   

Boc-L-2,4-diaminobutyric acid

Boc-L-2,4-diaminobutyric acid

C9H18N2O4 (218.1267)


   

4-(2-Fluorophenyl)-1-Methylpiperidine-4-carbonitrile

4-(2-Fluorophenyl)-1-Methylpiperidine-4-carbonitrile

C13H15FN2 (218.1219)


   

3-Morpholino-1H-indazol-5-amine

3-Morpholino-1H-indazol-5-amine

C11H14N4O (218.1168)


   

4-(6-METHOXY-2-METHYLPYRIDIN-3-YL)-3-METHYL-1H-PYRAZOL-5-AMINE

4-(6-METHOXY-2-METHYLPYRIDIN-3-YL)-3-METHYL-1H-PYRAZOL-5-AMINE

C11H14N4O (218.1168)


   

(1-(4-Methoxybenzyl)-1H-1,2,4-triazol-5-yl)methanamine

(1-(4-Methoxybenzyl)-1H-1,2,4-triazol-5-yl)methanamine

C11H14N4O (218.1168)


   

(8S,2S)-Diaminononanedioic acid

(8S,2S)-Diaminononanedioic acid

C9H18N2O4 (218.1267)


   

1H-Benzotriazole,1-(4-morpholinylmethyl)-

1H-Benzotriazole,1-(4-morpholinylmethyl)-

C11H14N4O (218.1168)


   

3-[[(1,1-Dimethylethoxy)carbonyl]amino]-L-alanine methyl ester

3-[[(1,1-Dimethylethoxy)carbonyl]amino]-L-alanine methyl ester

C9H18N2O4 (218.1267)


   

2,8-diaminononanedioic acid

2,8-diaminononanedioic acid

C9H18N2O4 (218.1267)


   

(2-FORMYLPHENYL)BORONIC ACID NEOPENTYL GLYCOL ESTER

2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)benzaldehyde

C12H15BO3 (218.1114)


   

t-Hexyl peroxy isopropyl monocarbonate

t-Hexyl peroxy isopropyl monocarbonate

C10H18O5 (218.1154)


   

3-(4-Morpholinyl)-1H-pyrrolo[2,3-b]pyridin-5-amine

3-(4-Morpholinyl)-1H-pyrrolo[2,3-b]pyridin-5-amine

C11H14N4O (218.1168)


   

(R)-4-AMINOMETHYL-THIAZOLIDINE-3-CARBOXYLICACIDTERT-BUTYLESTER

(R)-4-AMINOMETHYL-THIAZOLIDINE-3-CARBOXYLICACIDTERT-BUTYLESTER

C9H18N2O2S (218.1089)


   

(+)-Menthyl Chloroformate

(+)-Menthyl Chloroformate

C11H19ClO2 (218.1074)


   

N-(2-Ethoxybenzyl)-1H-1,2,4-triazol-5-amine

N-(2-Ethoxybenzyl)-1H-1,2,4-triazol-5-amine

C11H14N4O (218.1168)


   

N-Boc-glycine N-methoxy-N-methylamide

N-Boc-glycine N-methoxy-N-methylamide

C9H18N2O4 (218.1267)


   

diethylenglykol-diglycidylether

diethylenglykol-diglycidylether

C10H18O5 (218.1154)


   

Naphthalene, 2-p-tolyl- (6CI,7CI)

Naphthalene, 2-p-tolyl- (6CI,7CI)

C17H14 (218.1095)


   

6-(3,4-Diaminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone

6-(3,4-Diaminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone

C11H14N4O (218.1168)


   

(R)-Diisopropyl 2-hydroxysuccinate

(R)-Diisopropyl 2-hydroxysuccinate

C10H18O5 (218.1154)


   

Boc-D-2,4-Diaminobutyric Acid

Boc-D-2,4-Diaminobutyric Acid

C9H18N2O4 (218.1267)


   

3-Amino-N-Boc-L-alanine methyl ester

3-Amino-N-Boc-L-alanine methyl ester

C9H18N2O4 (218.1267)


   

boc-(s)-2-amino-3-(methylamino)propanoic acid

boc-(s)-2-amino-3-(methylamino)propanoic acid

C9H18N2O4 (218.1267)


   

Methyl-2-phenylnaphthalene

Methyl-2-phenylnaphthalene

C17H14 (218.1095)


   

Methyldihydrofluoranthene

Methyldihydrofluoranthene

C17H14 (218.1095)


   

N-[2-(2-Amino-benzoimidazol-1-yl)-ethyl]-acetamide

N-[2-(2-Amino-benzoimidazol-1-yl)-ethyl]-acetamide

C11H14N4O (218.1168)


   

(1R,2S,5R)-2-isopropyl-5-methylcyclohexylcarbonochloridate

(1R,2S,5R)-2-isopropyl-5-methylcyclohexylcarbonochloridate

C11H19ClO2 (218.1074)


   

piperidin-3-yl(pyrrolidin-1-yl)methanone,hydrochloride

piperidin-3-yl(pyrrolidin-1-yl)methanone,hydrochloride

C10H19ClN2O (218.1186)


   

2-(1,4-Diazepan-1-yl)oxazolo[5,4-b]pyridine

2-(1,4-Diazepan-1-yl)oxazolo[5,4-b]pyridine

C11H14N4O (218.1168)


   

(3 4-DIHYDRO-1-NAPHTHYLOXY)TRIMETHYL-

(3 4-DIHYDRO-1-NAPHTHYLOXY)TRIMETHYL-

C13H18OSi (218.1127)


   

[4-(cyclopentanecarbonyl)phenyl]boronic acid

[4-(cyclopentanecarbonyl)phenyl]boronic acid

C12H15BO3 (218.1114)


   

4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)benzaldehyde

4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)benzaldehyde

C12H15BO3 (218.1114)


   
   

([2-[(tert-Butoxycarbonyl)amino]ethyl]amino)acetic acid

([2-[(tert-Butoxycarbonyl)amino]ethyl]amino)acetic acid

C9H18N2O4 (218.1267)


   

Propanedioic acid,2-(ethoxymethyl)-, 1,3-diethyl ester

Propanedioic acid,2-(ethoxymethyl)-, 1,3-diethyl ester

C10H18O5 (218.1154)


   

Ethyl 4,4-diethoxy-3-oxobutanoate

Ethyl 4,4-diethoxy-3-oxobutanoate

C10H18O5 (218.1154)


   

Diethyl Propane-1,3-Diylbiscarbamate

Diethyl Propane-1,3-Diylbiscarbamate

C9H18N2O4 (218.1267)


   
   

N(6)-(1-Carboxyethyl)-L-lysine

N(6)-(1-Carboxyethyl)-L-lysine

C9H18N2O4 (218.1267)


A L-lysine derivative formed during the reaction between methylglyoxal and protein. CEL is a homologue of N(epsilon)-(carboxymethyl)lysine (CML), an advanced glycation end-product that is formed on reaction of glyoxal or glycolaldehyde with protein and on oxidative cleavage of fructoselysine, the Amadori adduct formed on glycation of protein by glucose.

   

N(6)-(2-carboxyethyl)-L-lysine

N(6)-(2-carboxyethyl)-L-lysine

C9H18N2O4 (218.1267)


   

H-L-Lys(Lactoyl)-OH

H-L-Lys(Lactoyl)-OH

C9H18N2O4 (218.1267)


   

9-Methyl-10-vinylanthracene

9-Methyl-10-vinylanthracene

C17H14 (218.1095)


   

nz-(1-carboxyethyl)-lysine

nz-(1-carboxyethyl)-lysine

C9H18N2O4 (218.1267)


   

N(6)-(1-Carboxyethyl)-L-lysine

2-amino-6-[(1-carboxyethyl)amino]hexanoic acid

C9H18N2O4 (218.1267)


   

(2S)-6-azaniumyl-2-{[(1R)-1-carboxylatoethyl]azaniumyl}hexanoate

(2S)-6-azaniumyl-2-{[(1R)-1-carboxylatoethyl]azaniumyl}hexanoate

C9H18N2O4 (218.1267)


   

3-[(5-Aminopentyl)hydroxycarbamoyl] propanoate

3-[(5-Aminopentyl)hydroxycarbamoyl] propanoate

C9H18N2O4 (218.1267)


   

L-Leucyl-L-serine

L-Leucyl-L-serine

C9H18N2O4 (218.1267)


   

L-Isoleucyl-L-serine

L-Isoleucyl-L-serine

C9H18N2O4 (218.1267)


   

Threonyl-valine

Threonyl-valine

C9H18N2O4 (218.1267)


   

L-Valyl-L-threonine

L-Valyl-L-threonine

C9H18N2O4 (218.1267)


   

2,6-diaminononanedioic acid

2,6-diaminononanedioic acid

C9H18N2O4 (218.1267)


   

epsilon-(Carboxyethyl)lysine

epsilon-(Carboxyethyl)lysine

C9H18N2O4 (218.1267)


   

Serinyl-isoleucine

Serinyl-isoleucine

C9H18N2O4 (218.1267)


   

((Z)-5-Chloropent-1-enyl)triethylsilane

((Z)-5-Chloropent-1-enyl)triethylsilane

C11H23ClSi (218.1257)


   

Alanylglycine, TMS derivative

Alanylglycine, TMS derivative

C8H18N2O3Si (218.1087)


   

Methyl 3,4-O-isopropylidene-beta-D-fucopyranoside

Methyl 3,4-O-isopropylidene-beta-D-fucopyranoside

C10H18O5 (218.1154)


   

Methyl 2,3-O-isopropylidene-alpha-L-rhamnopyranoside (2,2,2,3,3,3-D6)

Methyl 2,3-O-isopropylidene-alpha-L-rhamnopyranoside (2,2,2,3,3,3-D6)

C10H18O5 (218.1154)


   

Methyl 3,4-O-isopropylidene-beta-D-fucopyranoside (3,3,3,4,4,4-D6)

Methyl 3,4-O-isopropylidene-beta-D-fucopyranoside (3,3,3,4,4,4-D6)

C10H18O5 (218.1154)


   

1-O-Acetyl-2-O-valerylglycerol

1-O-Acetyl-2-O-valerylglycerol

C10H18O5 (218.1154)


   

(1-Hydroxy-3-propanoyloxypropan-2-yl) butanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) butanoate

C10H18O5 (218.1154)


   
   

N-(3-carboxypropanoyl)-N-hydroxycadaverine

N-(3-carboxypropanoyl)-N-hydroxycadaverine

C9H18N2O4 (218.1267)


   

Threoninyl-valine

Threoninyl-valine

C9H18N2O4 (218.1267)


   

N(epsilon)-(carboxyethyl)lysine

N(epsilon)-(carboxyethyl)lysine

C9H18N2O4 (218.1267)


   

5-Hydroxysebacate

5-Hydroxysebacate

C10H18O5 (218.1154)


   

Valylthreonine

Valylthreonine

C9H18N2O4 (218.1267)


   

D-lysopine dizwitterion

D-lysopine dizwitterion

C9H18N2O4 (218.1267)


A D-alpha-amino acid zwitterion that is D-lysopine arising from transfer of two protons from the carboxy to the amino groups; the major species at pH 7.3.

   

D-Lysopine

D-Lysopine

C9H18N2O4 (218.1267)


The N(2)-(R)-1-carboxyethyl derivative of L-lysine.

   

N1-Hydroxy-N1-succinylcadaverine

N1-Hydroxy-N1-succinylcadaverine

C9H18N2O4 (218.1267)


   

Hydroxydecanedioic acid

Hydroxydecanedioic acid

C10H18O5 (218.1154)


   

N(6)-(2-Carboxyethyl)-lysine

N(6)-(2-Carboxyethyl)-lysine

C9H18N2O4 (218.1267)


   

N-Lactoyl lysine

N-Lactoyl lysine

C9H18N2O4 (218.1267)


   

Tert-butoxycarbonyl anhydride

Tert-butoxycarbonyl anhydride

C10H18O5 (218.1154)


   

3-(chloromethyl)-6-methoxy-7-methylocta-2,7-dien-1-ol

3-(chloromethyl)-6-methoxy-7-methylocta-2,7-dien-1-ol

C11H19ClO2 (218.1074)


   

(2s)-2-({[(2s)-2-hydroxyoxolan-2-yl]methoxy}methyl)oxolan-2-ol

(2s)-2-({[(2s)-2-hydroxyoxolan-2-yl]methoxy}methyl)oxolan-2-ol

C10H18O5 (218.1154)


   

6-(chloromethyl)-8-methoxy-2-methylocta-1,6-dien-3-ol

6-(chloromethyl)-8-methoxy-2-methylocta-1,6-dien-3-ol

C11H19ClO2 (218.1074)


   

(3s,6z)-6-(chloromethyl)-8-methoxy-2-methylocta-1,6-dien-3-ol

(3s,6z)-6-(chloromethyl)-8-methoxy-2-methylocta-1,6-dien-3-ol

C11H19ClO2 (218.1074)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-hydroxypropanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-hydroxypropanoic acid

C9H18N2O4 (218.1267)


   

2-{[(2-hydroxyoxolan-2-yl)methoxy]methyl}oxolan-2-ol

2-{[(2-hydroxyoxolan-2-yl)methoxy]methyl}oxolan-2-ol

C10H18O5 (218.1154)


   

6,7,9-trihydroxydec-4-enoic acid

6,7,9-trihydroxydec-4-enoic acid

C10H18O5 (218.1154)


   

(4e,6s,7s,9s)-6,7,9-trihydroxydec-4-enoic acid

(4e,6s,7s,9s)-6,7,9-trihydroxydec-4-enoic acid

C10H18O5 (218.1154)


   

(2z,6s)-3-(chloromethyl)-6-methoxy-7-methylocta-2,7-dien-1-ol

(2z,6s)-3-(chloromethyl)-6-methoxy-7-methylocta-2,7-dien-1-ol

C11H19ClO2 (218.1074)